Suprarenal glands, also called adrenal glands, are triangular glands located on top of both kidneys. These glands produce hormones which help to regulate body’s immune system, blood pressure, and other essential homeostasis functions. Adrenal cortical hormones, also termed as steroid hormones, are polycyclic molecules that are produced in the adrenal gland by adrenal cortex located in its outer region. Adrenal cortical hormones are structurally similar to cholesterol and play a crucial role in regulating body’s response to physical injury, physiological stress, infection, chemical imbalances, and other functions in the body. Based on function, these hormones are categorized into three classes: androgens, mineralocorticoids, and glucocorticoids. Androgens, also called sex hormones, are responsible for promotion and maturation of human reproductive organs. Glucocorticoids process carbohydrates and fats, while mineralocorticoids are responsible for maintaining electrolyte concentration in the body.
Adrenal glands can cause serious health issues by either increasing production of certain hormones or producing too little. This leads to hormonal imbalances in human body. These anomalies of the adrenal glands functioning can be caused by numerous diseases/disorders of the pituitary gland or adrenal glands. Disorders due to adrenal deficiency is one of the most common disease that occurs worldwide. Adrenal deficiency might result in severe abdominal pain, depression, extremely low blood pressure, muscle weakness, weight loss, and others. Adrenal deficiency occurs primarily due to impairment of adrenal glands, pituitary glands, or the hypothalamus. It has been estimated that globally out of 100,000 people, one to four individuals is affected with Addison’s disease in all the age groups and the sexes. Additionally, nearly one in 10,000 people is affected by Addison’s disease in the U.K. Hence, increasing incidence of people suffering from adrenal deficiency due to changing lifestyle is a major driver of the adrenal cortical hormones and derivatives market. However, rise in cost of treatment, side effects in some of the treatments, are lack of reimbursement policies in developing countries are factors hampering the growth of the global adrenal cortical hormones and derivatives market.
Various disorders such as Cushing’s syndrome, Addison’s disease, and others are caused due to imbalance of these hormones. Several screening tests such as ACTH stimulation test and CRH stimulation test are performed to check adrenal deficiency. Similarly, ultrasound or X-ray test of abdomen is performed to detect the presence of calcium deposition which may indicate signs of bleeding in adrenal gland or tuberculosis. Several medications such as replacement corticoids are available for the treatment of adrenal deficiency.
The global adrenal cortical hormones and derivatives market can be segmented based on type of disorder and end-user. In terms of type of disorder, the market can be classified into Cushing’s syndrome, Addison’s disease, and others. Based on end-user, the global adrenal cortical hormones and derivatives market can be segmented into hospitals, diagnostic centers, academic & research institutes, and others.
Geographically, the global adrenal cortical hormones and derivatives market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds a major share of the market due factors such as presence of key players, technological advancements in the region, well-established health care infrastructure with reimbursement policies. The adrenal cortical hormones and derivatives market in Asia Pacific is expected to grow rapidly in the next few years due to increase in geriatric population, investments by key industries, and government initiatives to invest in health care.
Key players in the global adrenal cortical hormones and derivatives market are Pfizer, Inc. Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., and AbbVie, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.